Min. Order: | 1000 Piece/Pieces |
---|---|
Trade Term: | FOB,CFR,CIF,DAT,FAS,DDP,DAP,CIP,CPT,FCA,EXW |
Payment Terms: | Paypal, L/C, D/P, D/A, T/T, WU, Money Gram |
Supply Ability: | 1,000,000.00/Month |
Place of Origin: | Jiangsu |
Location: | Nanjing, Jiangsu, China (Mainland) |
---|---|
Business Type: | Manufacturer |
Model No.: | H-FABP |
---|---|
Means of Transport: | Ocean, Air, Land |
Brand Name: | NORMAN |
Methodology: | Chemiluminescence immunoassay |
Brand Name: | Norman |
Place of Origin: | Jiangsu, China (Mainland) |
Quality system certificate: | ISO13485 |
Test quantity of one box: | 100 test |
Reagent type: | liquid |
Test platform: | Norman 411 |
Production Capacity: | 1,000,000.00/Month |
Packing: | CARTON |
Delivery Date: | TWO WEEKS AFTER PAYMENT |
Heart-type Fatty Accid Binding Protein
immuno assay- H/FBP (chemiluminescence )
H-FABP
Registration No: Jiangsu food and drug administration 2014-2400619
H-FABP increase in 30 minutes after Acute Myocardial Infarction(AMI) occurred ,
Early marker of AMI.
Mainly indicated in the heart,high specificity for diagnosis of AMI
Clinical Signifacanse
Early specific markers of AMI
Rapid risk stratification of AMI
Early prognosis Evaluation ofAMI patients
Perfect markers for early testing of re-infarction
Norman Advantages
Hign sensitivity:0.5ng/ml
High accuracy: 99% result correlation with Hycult H-FABP ELISA
Wide Linear range:0.5-160ng/ml
Correlation analysis between Norman H-FABP and Hycult H-FABP ELISA
Significance of united application of H-FABP
and cTnI
Conductively screen out patients with high risk of heart disease ifH-FABP is tested
at early phaseand cTnIis tested at recovery phase.
Not only convenient to take active treatment strategies, but also save the expenses
of patients and laboratory resources.
Complementary test of H-FABP and cTnIis aperfect choice for clinical diagnosis and
treatment of ischemic heart disease.
Assay platform
Norman chemiluminesence immunassay system
Related assays
About us
Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of
in vitro diagnostic instruments and reagents. .Founded in 2008, Norman biological has
been upholding the idea that R&D shapes future ,and concentration determines success.
Ever since the beginning, Norman has been focusing on developing and manufacturing
chemiluminescence and immunofluorescence reagents.
Agent Wanted
If you are interested in working with us, please feel free to contact.